Browsing by Author Kalef-Ezra, E

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
22-Jun-2026Dysregulation of sphingolipid-metabolizing enzymes in Friedreich’s ataxia: In vitro and in vivo insights into therapeutic targetingRamchunder, Z; Kalef-Ezra, E; Suleman, S; Edzeamey, FJ; Szunyogh, S; Gittins, O; Mena, NC; Wade-Martins, R; Valle, A; Pourzand, C; Anjomani Virmouni, S
14-Nov-2019Elucidation of the metabolic signature of Friedreich’s ataxiaAnjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Perry, N; Tripp, A; Agliano, A; Al-Mahdawi, S; Pook, M
14-Nov-2019Genotype and Phenotype Characterisation of an Enhanced Friedreich Ataxia GAA Repeat Expansion Mouse Model Fxn_null::YG8s(GAA)>800Anjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Kleine, P; Oggianu, C; Hannana, T; Al-Mahdawi, S; Pook, M
5-Jun-2020HMTase Inhibitors as a Potential Epigenetic-based Therapeutic Approach for Friedreich’s AtaxiaSherzai, M; Valle, A; Perry, N; Kalef-Ezra, E; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S
26-Jan-2023A new FRDA mouse model [Fxnnull:YG8s(GAA) > 800] with more than 800 GAA repeatsKalef-Ezra, E; Edzeamey, FJ; Valle, A; Khonsari, H; Kleine, P; Oggianu, C; Al-Mahdawi, S; Pook, MA; Anjomani Virmouni, S
13-May-2026Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich’s ataxia modelsPido-Lopez, J; Moula, SE; Shaban, E; Stamatiou, K; Critchley, BJ; Whittaker, TE; Svensson, S; Anjomani Virmouni, S; Kalef-Ezra, E; Carr, L; Hassel, J; Thrasher, AJ; Kurian, MA; Blair, IA; Rojsajjakul, T; Santilli, G; Sala, A